Gain Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.13

-0.04 (-1.62%)

As of Aug 15, 2:21 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,310.8% upside

Low Target $22.12

Average Target $30.05

High Target $38.96

Current Price $2.13

Current
$2.13

Target
$30.05

$22.12 $30.05 avg $38.96

Scenario Analysis

Bear Case

$22.12

938.5%

Low target

Base Case

$30.05

+1,310.8%

Avg target

Bull Case

$38.96

+1,729.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.34

-50.9% from high

52-Week Low

$1.48

+43.9% from low

Target vs 52W High

$30.05

+592.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%